TruBridge, Inc. (TBRG)
(Delayed Data from NSDQ)
$11.37 USD
+0.40 (3.65%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $11.35 -0.02 (-0.18%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum A VGM
TruBridge (TBRG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$11.20 | $13.00 | $10.00 | 2.10% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for TruBridge comes to $11.20. The forecasts range from a low of $10.00 to a high of $13.00. The average price target represents an increase of 2.1% from the last closing price of $10.97.
Analyst Price Targets (5 )
Broker Rating
TruBridge currently has an average brokerage recommendation (ABR) of 2.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.40 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, one is Strong Buy and one is Buy. Strong Buy and Buy each account for 20% of all recommendations. A month ago, Strong Buy made up 20%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.40 | 2.40 | 2.40 | 2.40 | 2.40 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/28/2024 | Not Identified | Not Identified | Not Available | Moderate Buy |
3/1/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
1/22/2024 | Not Identified | Not Identified | Hold | Hold |
10/18/2023 | Stephens | Jeffrey Garro | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.40 |
ABR (Last week) | 2.40 |
# of Recs in ABR | 5 |
Average Target Price | $11.20 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 69 of 252 |
Current Quarter EPS Est: | 0.19 |